Literature DB >> 29136726

[Chinese expert consensus on the diagnosis and treatment of hypertension in the elderly(2017)].

.   

Abstract

China has stepped into an aging society. Hypertension is an independent risk factor of cardio-cerebrovascular diseases and related to mortality and disability of the elderly. Compared to middle-aged and young patients with similar blood pressure elevation, the risks of cardiovascular and cerebrovascular events significantly increase in the elderly. Since the Chinese expert consensus on the diagnosis and treatment of hypertension in the elderly(2008, 2011 version) were published, many guidelines have been accordingly updated, which further improved the prevention and control strategy of hypertension. In this article, Chinese expert consensus on the diagnosis and treatment of hypertension in the elderly(2017) is revised as to facilitate the prevention and treatment of hypertension in Chinese elderly. The consensus is composed of eight parts, including definition, epidemiology, characteristics, evidence, treatment objectives and measurements of elderly hypertension. The purpose of the consensus is to provide guidance for management of elderly hypertensive patients.

Entities:  

Keywords:  Elderly; Hypertension

Mesh:

Substances:

Year:  2017        PMID: 29136726     DOI: 10.3760/cma.j.issn.0578-1426.2017.11.024

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  9 in total

1.  Trace Element Levels in the Elders over 80 from the Hainan Province of China.

Authors:  Q Zhu; Y Yao; C-X Ning; Y-L Zhao
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

2.  Relationships of Sex Hormone Levels with Activity of Daily Living in Chinese Female Centenarians.

Authors:  S Fu; Y Yao; F Lv; F Zhang; Y Zhao; F Luan
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

3.  Association Between Late-Life Blood Pressure and the Incidence of Cognitive Impairment: A Community-Based Prospective Cohort Study.

Authors:  Jin-Qiu Yuan; Yue-Bin Lv; Hua-Shuai Chen; Xiang Gao; Zhao-Xue Yin; Wen-Tao Wang; Virginia Byers Kraus; Jie-Si Luo; Jiao-Nan Wang; Yi Zeng; Chen Mao; Xiao-Ming Shi
Journal:  J Am Med Dir Assoc       Date:  2018-07-14       Impact factor: 4.669

4.  Thyroid nodules in centenarians: prevalence and relationship to lifestyle characteristics and dietary habits.

Authors:  Yao Yao; Xianghui Chen; Shengzheng Wu; Liang Guo; Hao Zhang; Qiao Zhu; Jie Tang; Fuxin Luan; Yali Zhao; Faqin Lv; Yao He
Journal:  Clin Interv Aging       Date:  2018-04-03       Impact factor: 4.458

5.  Association of methylenetetrahydrofolate reductase (MTHFR) variant C677T and risk of carotid atherosclerosis: a cross-sectional analysis of 730 Chinese Han adults in Chongqing.

Authors:  Xulei Peng; Yongli Zhou; Xiaoxing Wu; Xiaolin Wang; Huili Bai; Yongqiang Li; Zhichao Wang; Xuan Chen; Yonghong Wang
Journal:  BMC Cardiovasc Disord       Date:  2020-05-13       Impact factor: 2.298

6.  Prevalence of metabolic syndrome risk factors and their relationships with renal function in Chinese centenarians.

Authors:  Shihui Fu; Yao Yao; Fuxin Luan; Yali Zhao
Journal:  Sci Rep       Date:  2018-06-29       Impact factor: 4.379

7.  Low body mass is associated with reduced left ventricular mass in Chinese elderly with severe COPD.

Authors:  Jing Zhang; Gang Li; Jari A Laukkanen; Cheng Liu; Xing Song; Yuqi Zhu
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

8.  Association of masked uncontrolled hypertension and cardiovascular diseases in treated hypertensive patients.

Authors:  Xiaoyang Shi; Kai Zhang; Pengxu Wang; Quane Kan; Junpeng Yang; Limin Wang; Huijuan Yuan
Journal:  Arch Med Sci       Date:  2019-10-30       Impact factor: 3.318

9.  Associations of immunological factors with metabolic syndrome and its characteristic elements in Chinese centenarians.

Authors:  Shihui Fu; Yao Yao; Faqin Lv; Fu Zhang; Yali Zhao; Fuxin Luan
Journal:  J Transl Med       Date:  2018-11-19       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.